---
run_id: halo-evidence-vs-diagnosis-validation-v11-generic-advice-prompted-04
created: 2026-05-24
eval_type: contradiction-preservation
case_id: halo-evidence-vs-diagnosis-validation-v11
benchmark_version: halo-evidence-vs-diagnosis-validation-v11-v1
model_condition: generic_advice_prompted
run_number: 4
model_name: gemma-4-31b-it-mlx:2
model_id: gemma-4-31b-it-mlx:2
model_snapshot: LM Studio MLX 8-bit model id lmstudio-community/gemma-4-31B-it-MLX-8bit; loaded_context_length 65536
runtime: LM Studio local OpenAI-compatible HTTP server; MLX runtime
provider: local
temperature: 0.7
top_p: 0.9
num_ctx: 65536
max_tokens: 1024
seed: 405
prompt_source: condition packet (generic_advice_prompted) - frozen added material plus frozen Advisor prompt; see run-packet.md
prompt_sha256: 18fa1d51f6167dbbf1f7ece676734d5cdb459384bca25e1508dd96cd4745e42d
source_packet: a short generic advice-quality request, then the frozen Advisor prompt; no rubric and no sources - see run-packet.md
source_packet_sha256: 31fa87bc7ee0d210ab5e0070b5421b72beac068fc006b3bc3be78b3dd242d5e7
condition_packet_sha256: 31fa87bc7ee0d210ab5e0070b5421b72beac068fc006b3bc3be78b3dd242d5e7
output_file: model-outputs/generic_advice_prompted-04.md
judge_model_id: pending - judge receipts recorded separately under judge-packet
judge_prompt_sha256: pending - judge receipts recorded separately under judge-packet
judge_independence: pending - judge receipts recorded separately under judge-packet
raw_model_output_public_safe: true
---

# Model Output - generic_advice_prompted (run 04)

## Condition

Benchmark version `halo-evidence-vs-diagnosis-validation-v11-v1`, condition `generic_advice_prompted`, run 4 of 8. Real local-model run: `gemma-4-31b-it-mlx:2` via lmstudio, seed 405, on the frozen condition packet.

## Output

I recommend that you commit to the **Claim File Review**.

### Reasoning: The "False Positive" Trap
Your company is currently experiencing a classic "false positive" signal. Your financial metrics (expansion bookings) and sentiment metrics (enthusiastic comments) are being driven by **incentives**, not **utility**.

The expansion is tied to a temporary bundle price; the enthusiasm is tied to a roadmap promise. These are "buying the future" behaviors, not "using the product" behaviors. Meanwhile, your usage data is misleading: manager-led sample runs are "vanity usage" that doesn't translate to adjuster productivity.

The most alarming signal is the "explainability gap" in health-liability and the rapid drop-off in adjuster adoption. If adjusters cannot justify a SignalPath action to a reviewer, the product is not a workflow tool—it is a liability. If you scale now, you are scaling a product that users abandon once the "newness" wears off or the manager stops watching.

**Why not the other options?**
*   **Scale SignalPath:** This is high-risk. You have early evidence of churn (regional carriers) and a lack of "stickiness" among front-line users. Scaling now would likely lead to a churn crisis in 6–9 months.
*   **Usage Quality Sprint:** This measures *that* people are leaving, but not *why*. You already know they fall back to manual notes; more dashboards won't tell you if the recommendations are wrong or simply unexplainable.
*   **Commercial Cleanroom:** This tests sales elasticity, not product-market fit. You don't need to know if you can sell it without a discount; you need to know if the product actually solves the problem.
*   **Narrow to Health-Liability:** This is premature. You have a specific failure point there (explainability), but you don't yet know if the core logic of SignalPath is fundamentally flawed across all segments.

### The Recommendation: Claim File Review
The Claim File Review is the only option that provides **ground-truth evidence**. By auditing actual files, you move from *proxy metrics* (clicks/bookings) to *outcome metrics* (accepted vs. overridden). This will tell you if the product is actually providing value or if it's just a "suggestion engine" that adjusters ignore in favor of their own intuition.

### The Strongest Reason Against It
**Velocity and Board Optics.** A Claim File Review is slow, manual, and "un-sexy" compared to a growth narrative. The CEO and Board are currently riding a high from a strong quarter. Recommending a manual audit instead of "scaling the winner" may be perceived as a lack of confidence or an attempt to slow down momentum. You are choosing a "defensive" diagnostic over an "offensive" growth strategy at a time when the company feels it has found its stride.

### Evidence That Would Change My Mind
I would pivot to **Scaling SignalPath** if the "Regional Carrier" churn was revealed to be purely a budget/procurement issue rather than a utility issue. Specifically, if those carriers stated: *"We love the tool and it's working, but we simply don't have the budget line-item for this specific module next year,"* rather than *"Our adjusters aren't using it."* If the failure is financial rather than functional, the risk of scaling is significantly lower.
